Clinical trial
Phase I Study of Stem Cell Mediated Angiogenesis for Limb Threatening Ischemia
NCT00113243 is registered in ClinicalTrials.gov with Murphy, Michael P., MD as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase I Study of Stem Cell Mediated Angiogenesis for Limb Threatening Ischemia
- Lead sponsor
- Murphy, Michael P., MD
- Phase
- Phase 1
- Overall status
- Unknown status
- Start date
- December 31, 2004
- Completion date
- December 31, 2007
- Enrollment
- 20
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.